Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III (vol 7, 2018)SCIENTIFIC REPORTSIF3.92018-07-040OAAI
Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapyFASEB JOURNALIF4.22017-09-1912PREAI
Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin AnalogsSCIENTIFIC REPORTSIF3.92017-04-2443OAAI
Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and IIISCIENTIFIC REPORTSIF3.92017-02-2133OAAI